Skip to content
10-K

Annual Report

LEXARIA BIOSCIENCE CORP. LEXX

0001640334-24-001787

← back to feed
Filed
Nov 26, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Nov 25, 2024 17.45M sh
Revenue FY 2024 · Aug 31, 2024 $464.28K
Revenue FY 2024 · Aug 31, 2023 $226.21K
Shares Diluted FY 2024 · Aug 31, 2023 6.61M sh
Capex FY 2024 · Aug 31, 2023 $33.75K
Operating Cash Flow FY 2024 · Aug 31, 2023 −$5.88M
Stockholders Equity FY 2024 · Aug 31, 2023 $3.04M
Current Liabilities FY 2024 · Aug 31, 2023 $267.74K
Total Liabilities FY 2024 · Aug 31, 2023 $403.91K
Current Assets restated FY 2024 · Aug 31, 2023 $2.15M
Total Assets FY 2024 · Aug 31, 2023 $3.08M
Eps Diluted FY 2024 · Aug 31, 2023 −$1.01
Sga Expense FY 2024 · Aug 31, 2023 $3.06M
Rd Expense FY 2024 · Aug 31, 2023 $3.67M
Net Income FY 2024 · Aug 31, 2023 −$6.66M
Operating Income FY 2024 · Aug 31, 2023 −$6.53M
Gross Profit FY 2024 · Aug 31, 2023 $194.71K